Anpario plc (AIM:ANP)

Market Cap	106.17M +9.7%
Revenue (ttm)	48.75M +11.0%
Net Income	7.08M +37.7%
EPS	0.39 +32.5%
Shares Out	20.04M
PE Ratio	13.45
Forward PE	12.42
Dividend	0.13 (2.36%)
Ex-Dividend Date	Nov 12, 2026

Volume	34,788
Open	519.80
Previous Close	515.00
Day's Range	510.00 - 530.00
52-Week Range	391.11 - 580.00
Beta	1.06
Analysts	Strong Buy
Price Target	613.00 (+15.7%)
Est. Earnings	Dec 10, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Mol...

• Industry: Agricultural - Commodities/Milling
• Sector: Industrials
• Founded: 1996
• Employees: 162
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2025, Anpario's revenue was 47.18 million, an increase of 23.51% compared to the previous year's 38.20 million. Earnings were 6.75 million, an increase of 64.20%.

Analyst Summary

According to 2 analysts, the average rating for ANP stock is "Strong Buy." The 12-month stock price target is 613p, which is an increase of 15.70% from the latest price.

Price Target

613p

(15.70% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error